Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Pil Gyu Hwang"'
Autor:
Zhanyong Bing, Pil Gyu Hwang, Yuan Yao, Theodore Xu, Amy Ziober, Erica Fan Clayton, Emma Elizabeth Furth
Publikováno v:
Rare Tumors, Vol 4, Iss 2, Pp e29-e29 (2012)
The clear cell variant of hepatocellular carcinoma is a rare entity, occurring at a frequency of less than 10% of hepatocellular carcinoma, with a female prevalence and usually associated with hepatitis C and cirrhosis. We reported a case of primary
Externí odkaz:
https://doaj.org/article/ae29678b5b814744b6ac54c2a4c1cca8
Autor:
Seock-Ah Im, Do Youn Oh, Tae-You Kim, Dong Wan Kim, Kyung Hun Lee, Pil Gyu Hwang, Sae-Won Han, Dae Seog Heo, Yoon Kyung Jeon, Doo Hyun Chung, Bhumsuk Keam, Se-Hoon Lee, Yung-Jue Bang
Publikováno v:
Pharmacogenetics and Genomics. 17:313-319
Objective Limited availability of tumoral tissue in non-small-cell lung cancer and presence of epidermal growth factor receptor mutation-independent responses call for investigation of other molecular predictive marker of gefitinib responsiveness. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebbaf3fb38d9e8e6cf4d9d15e39820f2
https://doi.org/10.1097/fpc.0b013e328011abc0
https://doi.org/10.1097/fpc.0b013e328011abc0
Autor:
Sae-Won Han, Dae Seog Heo, Do Youn Oh, Soohyun Jeong, Dong Wan Kim, Noe Kyeong Kim, Jeongmi Kim, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang, Pil Gyu Hwang, In Sil Choi, Young Tae Kim, Doo Hyun Chung, Jong-Seok Lee, Jee Hyun Kim
Publikováno v:
Journal of Clinical Oncology. 23:2493-2501
Purpose This study was undertaken to investigate the effects of epidermal growth factor receptor (EGFR) mutation and its downstream signaling on response and survival in non–small-cell lung cancer (NSCLC) patients treated with gefitinib. Patients a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e2e117faf680f973d9e386abb79f1a
https://doi.org/10.1200/jco.2005.01.388
https://doi.org/10.1200/jco.2005.01.388
Autor:
Seock-Ah Im, Dae Seog Heo, Yung-Jue Bang, Sae-Won Han, Pil Gyu Hwang, Noe Kyeong Kim, Tae-You Kim, Dong Wan Kim, Young Tae Kim, Doo Hyun Chung
Publikováno v:
International Journal of Cancer. 113:109-115
Gefitinib has shown meaningful antitumor activity with tolerable toxicity in chemotherapy-refractory NSCLC in previous studies. Moreover, EGFR expression failed to show a correlation with response. In an attempt to identify predictive markers of resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::950e9a8f9fbe8ff6a4aa6a4c5a9f2c6c
https://doi.org/10.1002/ijc.20550
https://doi.org/10.1002/ijc.20550
Autor:
Amy Ziober, Theodore Xu, Emma E. Furth, Zhanyong Bing, Pil Gyu Hwang, Yuan Yao, Erica F. Clayton
Publikováno v:
Rare Tumors
Rare Tumors, Vol 4, Iss 2, Pp e29-e29 (2012)
Rare Tumors, Vol 4, Iss 2, Pp e29-e29 (2012)
The clear cell variant of hepatocellular carcinoma is a rare entity, occurring at a frequency of less than 10% of hepatocellular carcinoma, with a female prevalence and usually associated with hepatitis C and cirrhosis. We reported a case of primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8048497d1bdd877fd45ec947182156e4
http://europepmc.org/articles/PMC3401157
http://europepmc.org/articles/PMC3401157
Autor:
Doo Hyun Chung, Do-Youn Oh, Tae-You Kim, Kyung-Hun Lee, Dae Seog Heo, Yung-Jue Bang, Dong Wan Kim, Seock-Ah Im, Sae-Won Han, Pil Gyu Hwang
Publikováno v:
Japanese journal of clinical oncology. 36(6)
Background: The association of epidermal growth factor receptor (EGFR) mutations with the response to conventional cytotoxic chemotherapeutic agents in non-small-cell lung cancer patients has not been investigated. We retrospectively analyzed the ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2a6c7d1c011a4b86625ce642567f8d1
https://pubmed.ncbi.nlm.nih.gov/16818479
https://pubmed.ncbi.nlm.nih.gov/16818479
Autor:
Seock-Ah Im, Dae Seog Heo, Do-Youn Oh, Doo Hyun Chung, Yoon Kyung Jeon, Sae-Won Han, Dong Wan Kim, Pil Gyu Hwang, Tae-You Kim, Kyung-Hun Lee, Se-Hoon Lee, Yung-Jue Bang
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 54(2)
Clinical predictors including Asian, female, adenocarcinoma and never-smoker and epidermal growth factor mutation are associated with gefitinib responsiveness in non-small-cell lung cancer. Direct comparison between clinical predictors and EGFR mutat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e18d8dafc5311a436dc31e4835baa39
https://pubmed.ncbi.nlm.nih.gov/16956694
https://pubmed.ncbi.nlm.nih.gov/16956694
Autor:
Kyung Joong, Oh, Bae Ju, Kwon, Moon Hee, Han, Pil Gyu, Hwang, Chong Jai, Kim, Dong Gyu, Na, Kee-Hyun, Chang
Publikováno v:
AJNR Am J Neuroradiol
Summary: Leiomyoma is a rare tumor arising from the uveal tract. Fundoscopically, it appears as a yellowish-white, elevated mass and cannot be readily distinguished from melanoma or other uveal tumors. Cross-sectional imaging may have an important ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::13d2ac019a265a33d7a1f4841557042c
https://pubmed.ncbi.nlm.nih.gov/15661710
https://pubmed.ncbi.nlm.nih.gov/15661710
Autor:
Sae-Won, Han, Pil Gyu, Hwang, Doo Hyun, Chung, Dong-Wan, Kim, Seock-Ah, Im, Young Tae, Kim, Tae-You, Kim, Dae Seog, Heo, Yung-Jue, Bang, Noe Kyeong, Kim
Publikováno v:
International journal of cancer. 113(1)
Gefitinib has shown meaningful antitumor activity with tolerable toxicity in chemotherapy-refractory NSCLC in previous studies. Moreover, EGFR expression failed to show a correlation with response. In an attempt to identify predictive markers of resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9818f606c2a6a6dad180f2a50c4a4199
https://pubmed.ncbi.nlm.nih.gov/15386420
https://pubmed.ncbi.nlm.nih.gov/15386420
Autor:
Pil Gyu Hwang, Doo Hyun Chung, Ji Yeon Kim, Seung Hee Lee, Hee Jung Kang, Young Tae Kim, Gene Lee, Hyun Cho Wi
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 28(1)
Objective: Unlike cardiac or renal xenotransplants, the depletion of complement using cobra venom factor (CVF) does not improve pulmonary xenograft survival. Several cases suggest that the swine von Willebrand factor (vWF) may play a major role in pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b13e5a9eb3f38cb0571bf68d968f05
https://pubmed.ncbi.nlm.nih.gov/15982598
https://pubmed.ncbi.nlm.nih.gov/15982598